Rapid Micro Biosystems (NASDAQ:RPID) Announces Quarterly Earnings Results

Rapid Micro Biosystems (NASDAQ:RPID) released its quarterly earnings results on Friday. The company reported ($0.27) earnings per share for the quarter, missing the consensus estimate of ($0.24) by ($0.03), FiscalAI reports. The firm had revenue of $8.05 million for the quarter, compared to analyst estimates of $7.88 million. Rapid Micro Biosystems had a negative return on equity of 131.52% and a negative net margin of 145.81%.

Here are the key takeaways from Rapid Micro Biosystems’ conference call:

• Second-quarter revenue rose 11% year over year to $8.1 million, exceeding guidance, with four Growth Direct Systems placed and nine validations completed. The company reached its 200th system placement milestone and reported record quarterly consumable revenue.
• Recurring revenue increased 14% to $5.0 million, supported by a larger installed base and higher system utilization, while consumable revenue grew more than 20%. Management expects further consumable and service growth in the second half.
• Gross margin improved to a record 15% from 4% a year earlier, driven by cost reductions, manufacturing efficiencies, service productivity, and operating leverage. The company expects at least 20% gross margin in Q3 and mid- to high-20% margins in Q4.
• Rapid Micro reaffirmed 2026 revenue guidance of $37 million to $41 million and system-placement guidance of 30 to 38 systems, while raising validation guidance to at least 27 systems. Management also expects a meaningfully stronger contribution from its MilliporeSigma collaboration in the second half.
• The company reported a $12.9 million quarterly net loss and ended the quarter with approximately $20 million in cash and short-term investments. Although cash usage is expected to decline, Rapid Micro remains dependent on cost reductions, improved operating performance, potential debt-facility tranches, and warrant proceeds to support its path to positive cash flow.

Rapid Micro Biosystems Stock Performance

Shares of Rapid Micro Biosystems stock opened at $1.73 on Friday. The business has a 50-day simple moving average of $1.90 and a 200 day simple moving average of $2.67. The firm has a market capitalization of $79.87 million, a price-to-earnings ratio of -1.54 and a beta of 1.44. The company has a debt-to-equity ratio of 0.93, a current ratio of 2.57 and a quick ratio of 1.66. Rapid Micro Biosystems has a one year low of $1.66 and a one year high of $4.94.

Analyst Ratings Changes

A number of analysts have recently weighed in on RPID shares. KeyCorp cut their target price on Rapid Micro Biosystems from $8.00 to $5.00 and set an “overweight” rating for the company in a research report on Friday, May 29th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Rapid Micro Biosystems in a report on Friday, July 17th. Lake Street Capital reduced their price objective on Rapid Micro Biosystems from $8.00 to $7.00 and set a “buy” rating on the stock in a research note on Friday, May 22nd. Finally, Wall Street Zen upgraded Rapid Micro Biosystems from a “strong sell” rating to a “sell” rating in a research report on Sunday, May 31st. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $6.00.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the business. Geode Capital Management LLC lifted its position in Rapid Micro Biosystems by 1.6% in the 2nd quarter. Geode Capital Management LLC now owns 204,079 shares of the company’s stock valued at $704,000 after acquiring an additional 3,143 shares in the last quarter. American Century Companies Inc. grew its position in Rapid Micro Biosystems by 46.1% in the 2nd quarter. American Century Companies Inc. now owns 16,922 shares of the company’s stock worth $58,000 after purchasing an additional 5,341 shares in the last quarter. XTX Topco Ltd bought a new stake in Rapid Micro Biosystems during the second quarter worth $144,000. Vanguard Group Inc. increased its position in shares of Rapid Micro Biosystems by 6.7% during the 3rd quarter. Vanguard Group Inc. now owns 965,018 shares of the company’s stock valued at $3,223,000 after purchasing an additional 60,655 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of Rapid Micro Biosystems by 37.8% in the 3rd quarter. Dimensional Fund Advisors LP now owns 55,642 shares of the company’s stock worth $186,000 after buying an additional 15,255 shares during the last quarter. 52.60% of the stock is currently owned by institutional investors and hedge funds.

About Rapid Micro Biosystems

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.